These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Serum levels of soluble Fas in patients with Graves' ophthalmopathy. Ohtsuka K; Hashimoto M Br J Ophthalmol; 2000 Jan; 84(1):103-6. PubMed ID: 10611108 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779 [TBL] [Abstract][Full Text] [Related]
9. Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin. Tellez M; Cooper J; Edmonds C Clin Endocrinol (Oxf); 1992 Mar; 36(3):291-4. PubMed ID: 1563082 [TBL] [Abstract][Full Text] [Related]
10. [Is incidence of diplopia after Fat Removal Orbital Decompression a predictive factor of choice of surgical technique for Graves' ophthalmopathy?]. Adenis JP; Camezind P; Robert PY Bull Acad Natl Med; 2003; 187(9):1649-58; discussion 1659-60. PubMed ID: 15369235 [TBL] [Abstract][Full Text] [Related]
11. More on smoking habits and Graves' ophthalmopathy. Bartalena L; Martino E; Marcocci C; Bogazzi F; Panicucci M; Velluzzi F; Loviselli A; Pinchera A J Endocrinol Invest; 1989 Nov; 12(10):733-7. PubMed ID: 2614012 [TBL] [Abstract][Full Text] [Related]
12. Treatment of Graves' disease and the course of ophthalmopathy. Sridama V; DeGroot LJ Am J Med; 1989 Jul; 87(1):70-3. PubMed ID: 2741983 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology and prevention of Graves' ophthalmopathy. Wiersinga WM; Bartalena L Thyroid; 2002 Oct; 12(10):855-60. PubMed ID: 12487767 [TBL] [Abstract][Full Text] [Related]
14. Proptosis is associated with thiol-disulfide in patients with Graves' ophthalmopathy. Acibucu F; Öztürk DD; Kizildag C; Aslan MZ; Gulumsek E; Sumbul MS; Neselioglu S; Erel O; Sen S; Bankir M; Sumbul HE Arch Endocrinol Metab; 2022 Apr; 66(2):191-197. PubMed ID: 35315985 [TBL] [Abstract][Full Text] [Related]
15. [Clinical manifestations of thyroid ophthalmopathy]. Fernández Hermida RV; Pinar S; Muruzábal N An Sist Sanit Navar; 2008; 31 Suppl 3():45-56. PubMed ID: 19169294 [TBL] [Abstract][Full Text] [Related]
16. Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy. De Bellis A; Bizzarro A; Conte M; Coronella C; Solimeno S; Perrino S; Sansone D; Guaglione M; Wall JR; Bellastella A Clin Endocrinol (Oxf); 2003 Sep; 59(3):388-95. PubMed ID: 12919164 [TBL] [Abstract][Full Text] [Related]
17. Natural history of graves' orbitopathy after treatment. Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471 [TBL] [Abstract][Full Text] [Related]
18. Clinical features of Graves' ophthalmopathy in an incidence cohort. Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA Am J Ophthalmol; 1996 Mar; 121(3):284-90. PubMed ID: 8597271 [TBL] [Abstract][Full Text] [Related]
19. Double vision is a major manifestation in moderate to severe graves' orbitopathy, but it correlates negatively with inflammatory signs and proptosis. Laurberg P; Berman DC; Pedersen IB; Andersen S; Carlé A J Clin Endocrinol Metab; 2015 May; 100(5):2098-105. PubMed ID: 25695893 [TBL] [Abstract][Full Text] [Related]
20. Reduction of diplopia following endoscopic orbital decompression: the orbital sling technique. Metson R; Samaha M Laryngoscope; 2002 Oct; 112(10):1753-7. PubMed ID: 12368609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]